J M Matsoukas

发表

Conformational and biological studies for a pair of novel synthetic AT1 antagonists: stereoelectronic requirements for antihypertensive efficacy.

T Mavromoustakos, S. Grdadolnik, A. Zoga, 2003, Journal of pharmaceutical and biomedical analysis.

The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II.

T Mavromoustakos, G. Moore, J. Matsoukas, 2000, Bioorganic & medicinal chemistry.

Design and pharmacology of peptide mimetics.

Joshua R. Smith, J R Smith, J R Smith, 1995, Advances in pharmacology.

Receptor interactions of the position 4 side chains of angiotensin II analogues: Importance of aromatic ring quadrupole

G. Moore, J. Sandall, K Barlos, 1994, Journal of molecular recognition : JMR.

Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation.

J M Matsoukas, E D Mantzourani, T M Mavromoustakos, 2005, Current medicinal chemistry.

Novel synthesis of cyclic amide-linked analogues of angiotensins II and III.

K Barlos, D Gatos, J M Matsoukas, 1994, Journal of medicinal chemistry.

Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II.

T Mavromoustakos, G. Moore, J. Matsoukas, 1994, The Journal of biological chemistry.

Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: relationship to biological activity and 1H-NMR data.

G. Moore, J. Matsoukas, R. Turner, 1990, Biochemical and biophysical research communications.

Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activity.

G. Moore, J. Matsoukas, R. Turner, 1991, Biochimica et biophysica acta.

Differences in backbone structure between angiotensin II agonists and type I antagonists.

T Mavromoustakos, J M Matsoukas, R Yamdagni, 1995, Journal of medicinal chemistry.

Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.

G. Moore, J. Matsoukas, J M Matsoukas, 1985, Journal of medicinal chemistry.

Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.

G. Moore, J. Matsoukas, J M Matsoukas, 1993, Journal of medicinal chemistry.

Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.

T Mavromoustakos, L. Probert, G. Moore, 1999, Journal of medicinal chemistry.